menu
    • menu

    Company profile for Solara Active Pharma Sciences

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value based products while maintaining focus on the customer needs. We have 140+ scie...
    Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value based products while maintaining focus on the customer needs. We have 140+ scientists working at our two R&D Centers and 4 API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Solara Active Pharma Sciencesindia-flag Flag
    Country
    Country
    India
    Address
    Address
    3rd & 4th Floor, Batra Centre, No.28, Sardar Patel Road, Guindy, Chennai – 6...
    Telephone
    Telephone
    +91 44 4344 6700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://solara.co.in/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/solara-active-pharma-sciences
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI WW Frankfurt

    Not Confirmed

    envelop Contact Supplier

    CPhI WW Frankfurt

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    "50 Years of Innovation: Mikart

    mic"50 Years of Innovation: Mikart's legacy and what's next in CDMO excellence"

    This week, SpeakPharma interviews Michael Kallelis, CEO of Mikart, a leading contract development and manufacturing organization (CDMO) celebrating its 50th anniversary in the pharmaceutical industry. Based in the United States, Mikart has built a reputation for technical expertise, flexible business terms, and specialized capabilities in pharmaceutical development services. In this exclusive interview, Kallelis discusses how Mikart maintains its competitive edge through its Pharmaceutical Development Services team, quality control framework, and commitment to customized business solutions. Kallelis also explores the company's focus on liquid suspensions manufacturing, driven by growing demand from aging populations and pediatric patients, and explains how Mikart balances traditional family business values with modern innovation. HIGHLIGHTS// celebrating its 50th anniversary/ reputation for technical expertise/ how Mikart maintains its competitive edge Mikart is celebrating 50 years in business this year — what are some of the major milestones that have shaped the company's journey?  Over our 50-year history, we've celebrated many memorable milestones, but one of the most significant in recent years has been achieving our growth objectives. This success was driven by the strategic expansion of our Pharmaceutical Development Services team, the completion of full aggregate serialization in our packaging department, modernization of our IT systems, enhanced productivity, and our ability to attract both new and returning customers. HIGHLIGHTS// expansion of our Pharmaceutical Development Services team/ completion of full aggregate serialization/ attract both new and returning customers How has Mikart maintained its competitive edge in a constantly evolving pharmaceutical landscape? Our customers consistently tell us that what sets us apart is our technical expertise, high service level, and flexible, customized business terms. At the core of our competitiveness is our focus on Pharmaceutical Development Services (PDS). Mikart's PDS opinion leaders are actively engaged in business development and form early, collaborative relationships with our customers' technical teams. From the outset, our prospects and clients work directly with Mikart's experienced formulation chemists, analytical method developers, and process-oriented engineers to design robust, reproducible, and efficient processes. This hands-on development approach is supported by a comprehensive quality control testing framework — covering raw material testing, in-process checks, on-site microbiological testing, and in-house stability studies. Oversight is provided by our robust Quality Management System, managed by a dedicated Quality Assurance and Regulatory Affairs team. The result is disciplined problem-solving, timely FDA submissions, and a "right-first-time" philosophy that accelerates time-to-market. We operate with a strong sense of urgency and consistently deliver a high level of customer satisfaction. What truly differentiates Mikart is our commitment to customized business terms that eliminate common roadblocks seen with other CDMOs. Our secret sauce is our exceptional service and flexibility in helping our customers bring innovative medicines to patients. HIGHLIGHTS// technical expertise, high service level/ flexible, customized business terms/ comprehensive quality control testing framework/ dedicated Quality Assurance and Regulatory Affairs team/ timely FDA submissions/ accelerates time-to-market What capabilities or services does Mikart offer today that didn't exist 10 or 20 years ago? Mikart was an early leader in serialization, implementing full capabilities well ahead of the industry timeline. This proactive approach has kept our packaging team in high demand. We also upgraded our tablet compression equipment to enhance both speed and reliability. To support growing development needs, we invested in new lab-scale development equipment, unit dose cup filling, sachet packaging, low-humidity suites, and a brand-new suite dedicated to closed-system manufacturing of liquids and suspensions. Most recently, we launched a multi-million dollar expansion of our packaging lines to support higher-speed tablet filling, powder-in-bottle formats, and new liquid fill capabilities. HIGHLIGHTS// early leader in serialization/ upgraded our tablet compression equipment/ multi-million dollar expansion of our packaging lines Why are liquid suspensions becoming such a key focus, and how is Mikart positioned? Formulating suspensions is a complex process that requires specialized expertise and equipment. According to our customers, few mid-market CDMOs do it well — and Mikart is one of them. There is growing industry demand for high-quality suspension manufacturing, driven by the needs of the aging baby boomer population and pediatric patients. For both groups, swallowing tablets or capsules can be difficult, making oral liquid suspensions a more practical alternative. In addition to being easier to administer, suspensions offer pharmacological advantages and can improve dosing compliance. Enhanced flavoring techniques further improve the patient experience — especially for children and infants — by making medicines more palatable. HIGHLIGHTS// growing industry demand for high-quality suspension manufacturing/ suspensions offer pharmacological advantages/ improve dosing compliance How does Mikart balance tradition with innovation to meet modern customer demands?  At Mikart, we work hard to preserve the values of a traditional family business, even as we continue to modernize. Our goal is to make every customer feel like they are our top priority. Each customer is supported by a dedicated project manager who serves as their primary point of contact, along with direct access to key team members across departments. This structure ensures our customers are never isolated from our subject matter experts and can get timely, accurate answers to their questions. We're also mindful of the "technology trap" — the tendency to pursue every new innovation at the expense of focus and efficiency. Instead, we rely on market data and customer trends to guide our investments, enabling us to concentrate our resources and capital on technologies that meet real market needs. HIGHLIGHTS// customer is supported by a dedicated project manager/ customers are never isolated from our subject matter experts/ we rely on market data and customer trends to guide our investments/ meet real market needs Looking ahead, what's in store for Mikart in the next 5-10 years? Mikart's strategic plan is now in full motion, and with the momentum we've built, 50 percent growth is within reach. This projection is backed by a strong pipeline of annual FDA filings, a growing customer base, and a robust portfolio of active Pharmaceutical Development Services projects. As we grow, we remain committed to delivering exceptional service and continuously evolving to meet the changing needs of our customers. With renewed political emphasis on domestic manufacturing for the US market, we are ideally positioned to support the rapid, cost-effective development and production of high-quality medicines here at home. As we approach our 50th anniversary in the CDMO industry, we celebrate our legacy and look forward with optimism to the opportunities ahead in the next 5 to 10 years. HIGHLIGHTS// 50 percent growth is within reach/ strong pipeline of annual FDA filings 

    Impressions: 2853

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence

    PharmaCompass
    17 Jul 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaIngredients for Innovative FormulationsIngredients for Innovative Formulations

    Ingredients for Innovative Formulations
    Ingredients for Innovative Formulations

    reelIngredients for Innovative Formulations

    This PharmaReel highlights Kirsch Pharma’s expertise in providing premium quality raw materials, custom blends, and tailor-made solutions. With 40+ years of expertise and certified quality (GMP, ISO 9001, FSSC 22000, Halal, Kosher), Kirsch supports pharma, biotech, and nutrition industries worldwide.

    Impressions: 1289

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

    Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

    Precise particle size control has become the cornerstone of modern pharmaceutical manufacturing. With highly potent active pharmaceutical ingredients (HPAPIs) and complex formulations driving unprecedented demand, micronization technology is no longer optional — it's critical. The market reflects this urgency. The global API micronization market will jump from US$ 2.47 billion in 2024 to US$ 3.68 billion by 2030 — a 49 percent surge driven by a robust 6.84 percent CAGR. What's powering this growth? Strategic innovation by industry leaders. Companies like Munit SA, Lonza, Catalent, Veranova, EUROAPI, AGC Pharma Chemicals, Hovione and Coral Drugs aren't just participating — they're defining the future of pharmaceutical particle engineering. The Micronization Landscape: How leading companies are advancing pharmaceutical particle engineering The API micronization space is being shaped by companies with specialized expertise. Munit’s proprietary fluid jet milling technology brings particle sizes down to the 1-micron level — critical for inhalation therapies. In addition, this technology enables precise control over particle size distribution without mechanical impact, making it ideal for heat-sensitive and high-potency APIs. With decades of hands-on experience, Munit ensures batch-to-batch consistency, scalability from R&D to commercial volumes, and full compliance with GMP standards.  Munit offers high-containment isolators — including glove boxes for R&D and half-suit isolators for larger batches — with industry-leading containment levels, limiting airborne drug exposure to as low as 0.025 micrograms per cubic meter. This makes it particularly well-suited for handling highly potent or sensitive compounds, exceeding the capabilities of other commercial-scale players like Catalent, who typically achieve containment levels of 0.05 micrograms per cubic meter or higher. EUROAPI has taken a broad particle engineering approach, offering both micronization and spray drying across multiple dosage routes — oral, inhaled, and parenteral. AGC Pharma Chemical leverages spray drying and amorphous solid dispersion technologies across small molecules, peptides, ADCs, and oligonucleotides, exemplifying the evolving intersection of particle engineering and modern drug delivery innovation. Coral Drugs delivers cutting-edge technology and customization capabilities that tailor particle sizes to specific client requirements across tablets, injectables, and topicals. This dynamic competitive landscape continues to evolve as companies expand capabilities and form strategic partnerships. This year, Dec Group announced the launch of their cutting-edge Micronization Suite, now operational in Brick, New Jersey, while Lonza joined the Centre for Continuous Manufacturing and Advanced Crystallisation, an international research hub, to develop innovative continuous processing and crystallization solutions. Selecting the right micronization partner: Key success factors In a pharmaceutical landscape increasingly defined by complexity, precision, and speed-to-market, the choice of a micronization partner can significantly influence a drug’s success. Among the players in this space, Munit SA has emerged as a trusted and strategic ally for pharmaceutical companies worldwide. But what exactly sets Munit apart in the micronization market? To begin with, Munit SA brings over 60 years of experience in particle size engineering. This legacy is not just a number; it reflects decades of accumulated knowledge, process refinement, and a deep understanding of how particle size impacts drug performance. In an industry where even minor deviations can compromise efficacy or safety, this level of experience is invaluable. It has delivered over 500 successful micronization projects to more than 150 customers globally. At its core, Munit SA is laser-focused on micronization and milling — not as ancillary services, but as its primary mission. Their facilities are designed for processing high-potency APIs, cytotoxic and cytostatic compounds, non-beta-lactam antibiotics, steroids, and controlled substances under stringent containment protocols. The company also handles inhalation products, peptides, biological drugs, generics, and R&D compounds. Whether it's micronization for ophthalmic formulations, transdermal or oral products, Munit offers a tailored approach. It stands as a world-leading provider of micronization services in inhalation powders with particle sizes of 1-5 microns and specialized oncology applications for small molecules. In an increasingly complex global landscape, Munit SA addresses supply chain challenges through its dual-site operational model, with facilities in Switzerland (Jetpharma SA) and Italy (Microchem S.r.l). This strategic setup mitigates risks from regulatory changes, geopolitical tensions, or environmental disruptions, ensuring continuous production and delivery of critical APIs. This resilience makes Munit a trusted partner for companies prioritizing business continuity. Why pharmaceutical companies choose Munit for advanced micronization and milling Munit’s proprietary MC Jet Mill is a testament to its engineering excellence. For heat-sensitive APIs, Munit’s cryogenic micronization process uses liquid nitrogen to cool materials, preventing thermal degradation and preserving the integrity of delicate molecules. This is particularly valuable for biologics and APIs with low melting points, where stability is paramount. Additionally, Munit’s under containment micronization employs advanced systems to safely handle HPAPIs, protecting both operators and the environment while meeting stringent regulatory standards.  Their co-micronization service, which processes APIs alongside excipients, further enhances formulation stability and solubility, offering innovative solutions for complex drug profiles. These capabilities, executed under Good Manufacturing Practices (GMP), make Munit a reliable choice for pharmaceutical companies seeking precision and quality. While micronization is Munit’s flagship, it offers milling services through an array of technologies, each suited to specific needs. The Pin Mill uses a grinding chamber and particle size reduction is achieved due impact against a high-speed pin rotor, producing sizes from 50 to 150 microns. It’s particularly effective for APIs needing improved flow for tableting, offering precise size control that ensures uniformity. The Quadro Co-Mill excels at soft de-lumping and homogenization, using a conical sieve and impeller to gently process powders without altering primary particle sizes. For tougher materials, the HammerMill C-10 employs hammer bars on a rotor to crush particles. State-of-the-Art Particle Engineering: Munit's strategic innovation push delivers next-gen solutions Munit’s leadership in micronization is underpinned by a deliberate and sustained investment in innovation — aimed at building the next generation of particle size engineering. In response to client challenges with condensation and product degradation, Munit developed a proprietary conditioning system that precisely controls humidity and temperature. Engineered with ergonomic design and fluid dynamics principles, their machine represents a qualitative leap in conditioning. Munit's new AIFA-approved Building C transforms the Italian hub's capacity. Equipped for high potent, toxic, cytotoxic, and cytostatic compounds, alongside hormones, it features cutting-edge safety systems and integrated technologies, enabling broader API processing with precision and compliance. Munit has merged quality assurance and regulatory affairs into one strategic unit, streamlining workflows and enhancing client responsiveness during critical validation phases. This delivers tailored regulatory support and accelerates time-to-market. These initiatives position Munit at the forefront of particle size engineering, where state-of-the-art innovation, regulatory excellence, and client-centric design converge to set new industry standards. Our view The API micronization market is projected to grow 49 percent to US$ 3.68 billion by 2030. In this evolving landscape, companies that combine deep technical expertise with operational resilience are positioned to capture the greatest value. Munit SA exemplifies this winning formula.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2758

    https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers

    #Phispers by PHARMACOMPASS
    10 Sep 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Solara Active Pharma Sciences Q1FY26 Pat Surges to Rs. 10.52 Cr
    Solara Active Pharma Sciences Q1FY26 Pat Surges to Rs. 10.52 Cr

    26 Jul 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/solara-active-pharma-sciences-consolidated-q1fy26-pat-rises-to-rs-1052-cr-17471

    INDPHARMAPOST
    26 Jul 2025
    Share Share
    Solara Active Pharma Sciences reports Rs. 2.10 Cr Q4 FY25 loss
    Solara Active Pharma Sciences reports Rs. 2.10 Cr Q4 FY25 loss

    18 May 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/solara-active-pharma-sciences-posts-q4-fy25-consolidated-loss-at-rs-210-cr-17174

    INDPHARMAPOST
    18 May 2025
    Share Share
    Solara Active Pharma reports profit of Rs 8.09 cr in Dec quarter
    Solara Active Pharma reports profit of Rs 8.09 cr in Dec quarter

    24 Jan 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/capital-market-news/solara-active-pharma-sciences-reports-consolidated-net-profit-of-rs-8-09-crore-in-the-december-2024-quarter-125012401035_1.html

    BUSINESS STD
    24 Jan 2025
    Share Share
    Solara Active Pharma Sciences Ltd Surges 2.77%
    Solara Active Pharma Sciences Ltd Surges 2.77%

    07 Jan 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/capital-market-news/solara-active-pharma-sciences-ltd-surges-2-77-125010700198_1.html

    BUSINESS STD
    07 Jan 2025
    Share Share
    Solara Active Pharma Reports Q2 FY25 Net Profit at Rs. 8.01 Cr
    Solara Active Pharma Reports Q2 FY25 Net Profit at Rs. 8.01 Cr

    23 Oct 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/solara-active-pharma-sciences-reports-consolidated-q2-fy25-net-profit-at-rs-801-cr-16351

    INDPHARMAPOST
    23 Oct 2024
    Share Share
    Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr
    Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr

    23 Jul 2024

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/solara-active-pharma-sciences-reports-q1-fy25-consolidated-loss-at-rs-1346-cr-15903

    INDIANPHARMAPOST
    23 Jul 2024
    Share Share

    USDMF

    read-more
    read-more

    01

    Acitretin

    India
    Cell Therapy
    Not Confirmed
    arrow

    02

    Acyclovir Sodium

    India
    Cell Therapy
    Not Confirmed
    arrow

    03

    Albendazole

    India
    Cell Therapy
    Not Confirmed
    arrow

    04

    Aprepitant

    India
    Cell Therapy
    Not Confirmed
    arrow

    05

    Artemether

    India
    Cell Therapy
    Not Confirmed
    arrow

    06

    Artesunate

    India
    Cell Therapy
    Not Confirmed
    arrow

    07

    Atracurium Besylate Usp

    India
    Cell Therapy
    Not Confirmed
    arrow

    08

    Brivaracetam

    India
    Cell Therapy
    Not Confirmed
    arrow

    09

    Bumetanide Usp

    India
    Cell Therapy
    Not Confirmed
    arrow

    10

    Buspirone Hydrochloride Usp

    India
    Cell Therapy
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    EU WC

    read-more
    read-more

    01

    Brivaracetam IH

    India
    Boulder Peptide
    Not Confirmed
    arrow

    02

    Bumetanide USP

    India
    Boulder Peptide
    Not Confirmed
    arrow

    03

    Buspirone Hydrochloride Ph.E...

    India
    Boulder Peptide
    Not Confirmed
    arrow

    04

    Buspirone Hydrochloride USP

    India
    Boulder Peptide
    Not Confirmed
    arrow

    05

    Carisoprodol USP

    India
    Boulder Peptide
    Not Confirmed
    arrow

    06

    Celecoxib USP/Ph. Eur

    India
    Boulder Peptide
    Not Confirmed
    arrow

    07

    Chlorphenesin BP

    India
    Boulder Peptide
    Not Confirmed
    arrow

    08

    Cinacalcet Hydrochloride IH

    India
    Boulder Peptide
    Not Confirmed
    arrow

    09

    Cinacalcet Hydrochloride IH

    India
    Boulder Peptide
    Not Confirmed
    arrow

    10

    Citicoline Sodium IP

    India
    Boulder Peptide
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Analytical

    Click here to discover the service providers for Analytical

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Inspections and registrations

    Upload your audits for free, ask us

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    Boulder Peptide
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Boulder Peptide
    Not Confirmed

    District Decision : Official Action Indicated

    Inspection End Date : 2020-03-07

    Solara Active Pharma Sciences

    City : Kudikkadu

    State :

    Country/Area : India

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Official Action Indicated

    Inspection End Date : 2020-03-07

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    Biotech Week Boston
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Biotech Week Boston
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2020-02-21

    Solara Active Pharma Sciences

    City : Mangalore

    State :

    Country/Area : India

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2020-02-21

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    Biotech Week Boston
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Biotech Week Boston
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2020-02-21

    Solara Active Pharma Sciences

    City : Puducherry

    State :

    Country/Area : India

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2020-02-21

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    Biotech Week Boston
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Biotech Week Boston
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2018-12-14

    Solara Active Pharma Sciences

    City : ChenNo Action Indicated

    State :

    Country/Area : India

    Zip :

    District : ORA

    Center : CDER

    Project Area : Bioresearch Monitoring

    District Decision : No Action Indicated

    Inspection End Date : 2018-12-14

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    Biotech Week Boston
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Biotech Week Boston
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-07-27

    Solara Active Pharma Sciences

    City : Mangalore

    State :

    Country/Area : India

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-07-27

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    Biotech Week Boston
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Biotech Week Boston
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2017-05-05

    Solara Active Pharma Sciences

    City : Puducherry

    State :

    Country/Area : India

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2017-05-05

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    FDA Audited

    USA
    Biotech Week Boston
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Biotech Week Boston
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2017-04-21

    Solara Active Pharma Sciences

    City : Kudikkadu

    State :

    Country/Area : India

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2017-04-21

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    FDA Audited

    USA
    Biotech Week Boston
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Biotech Week Boston
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2016-08-31

    Solara Active Pharma Sciences

    City : ChenNo Action Indicated

    State :

    Country/Area : India

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2016-08-31

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    09

    FDA Audited

    USA
    Biotech Week Boston
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Biotech Week Boston
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-07-03

    Solara Active Pharma Sciences

    City : Mangalore

    State :

    Country/Area : India

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-07-03

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    10

    FDA Audited

    USA
    Biotech Week Boston
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Biotech Week Boston
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-02-20

    Solara Active Pharma Sciences

    City : Puducherry

    State :

    Country/Area : India

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-02-20

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    GDUFA

    read-more
    read-more

    01

    GDUFA fees paid

    USA
    Boulder Peptide
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    Boulder Peptide
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2019

    Solara Active Pharma Sciences

    API Manufacturer : API MANUFACTURE

    FDF Manufacturer :

    Facility Name : SOLARA ACTIVE PHARMA SCIENCES ...

    Business Address : Plot Nos. 120 A & B, 36, 120...

    FEI Number : 3008252997

    Country : India

    Paid in : 2019

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    GDUFA fees paid

    USA
    Boulder Peptide
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    Boulder Peptide
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2021

    Solara Active Pharma Sciences

    API Manufacturer : API MANUFACTURE

    FDF Manufacturer :

    Facility Name : Solara Active Pharma Sciences ...

    Business Address : Plot No. N39/ N39-1, Anand n...

    FEI Number : 3008374690

    Country : India

    Paid in : 2021

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    GDUFA fees paid

    USA
    Boulder Peptide
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    Boulder Peptide
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2021

    Solara Active Pharma Sciences

    API Manufacturer : API MANUFACTURE

    FDF Manufacturer :

    Facility Name : Solara Active Pharma Sciences ...

    Business Address : Plot Nos. 36, 120 A & B, 120...

    FEI Number : 3008252997

    Country : India

    Paid in : 2021

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    GDUFA fees paid

    USA
    Boulder Peptide
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    Boulder Peptide
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2021

    Solara Active Pharma Sciences

    API Manufacturer : API MANUFACTURE

    FDF Manufacturer :

    Facility Name : Solara Active Pharma Sciences ...

    Business Address : A-1/B, Sipcot Industrial Com...

    FEI Number : 3003585876

    Country : India

    Paid in : 2021

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    GDUFA fees paid

    USA
    Boulder Peptide
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    Boulder Peptide
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2019

    Solara Active Pharma Sciences

    API Manufacturer : API MANUFACTURE

    FDF Manufacturer :

    Facility Name : SOLARA ACTIVE PHARMA SCIENCES ...

    Business Address : R.S.No.33 & 34, Mathur Road ...

    FEI Number : 3002808058

    Country : India

    Paid in : 2019

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    GDUFA fees paid

    USA
    Boulder Peptide
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    Boulder Peptide
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2021

    Solara Active Pharma Sciences

    API Manufacturer : API MANUFACTURE

    FDF Manufacturer :

    Facility Name : Solara Active Pharma Sciences ...

    Business Address : R.S.No 33 & 34, Mathur Road,...

    FEI Number : 3002808058

    Country : India

    Paid in : 2021

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    GDUFA fees paid

    USA
    Boulder Peptide
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    Boulder Peptide
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2019

    Solara Active Pharma Sciences

    API Manufacturer : API MANUFACTURE

    FDF Manufacturer :

    Facility Name : SOLARA ACTIVE PHARMA SCIENCES ...

    Business Address : A-1/B, Sipcot Industrial Com...

    FEI Number : 3003585876

    Country : India

    Paid in : 2019

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Solara Active Pharma Sciences and get a quotation

    Solara Active Pharma Sciences is a supplier offers 132 products (APIs, Excipients or Intermediates).

    Find a price of Oseltamivir Phosphate bulk with DMF, CEP, JDMF, WC offered by Solara Active Pharma Sciences

    Find a price of Levetiracetam bulk with DMF, CEP, JDMF offered by Solara Active Pharma Sciences

    Find a price of Aprepitant bulk with DMF, CEP, JDMF offered by Solara Active Pharma Sciences

    Find a price of Buspirone Hydrochloride bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Colchicine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Etomidate bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Flecainide bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Hydralazine Hydrochloride bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Mesna bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Praziquantel bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Succinylcholine Chloride bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Sulfiram bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Bumetanide bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Celecoxib bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Dextromethorphan Hydrobromide bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Dipyridamole bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Gabapentin bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Lanthanum Carbonate bulk with DMF, JDMF offered by Solara Active Pharma Sciences

    Find a price of Mesalazine bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Mycophenolate Mofetil bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Nizatidine bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Olanzapine bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Venlafaxine Hydrochloride bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Cetirizine Dihydrochloride bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Edaravone bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Imiquimod bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mefenamic Acid bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Methoxsalen bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mycophenolate Sodium bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Rifaximin bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Rotigotine bulk with DMF, JDMF offered by Solara Active Pharma Sciences

    Find a price of Brivaracetam bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Carisoprodol bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Cinacalcet Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Colesevelam Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Cycloserine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ethacrynic Acid bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Fluocytosine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Lysinate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Isradipine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ketoprofen bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Loratadine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Lurasidone Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Meprobamate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Methohexital bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Mirabegron bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Obeticholic Acid bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Pentoxifylline bulk with CEP offered by Solara Active Pharma Sciences

    Find a price of Pitavastatin bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Posaconazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ranitidine Hydrochloride bulk with CEP offered by Solara Active Pharma Sciences

    Find a price of Safinamide Methanesulfonate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Sapropterin Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Sevelamer Carbonate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Sevelamer Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Tenofovir Disoproxil Fumarate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Tioconazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Zileuton bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Acitretin bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Acyclovir Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Albendazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Artemether bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Artesunate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Atracurium Besylate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Buspirone Hydrochloride bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Chlorpromazine Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Chlorthalidone bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Citicoline Sodium bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Clomipramine Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Colestipol bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Dabigatran Etexilate Mesylate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Dextromethorphan bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Efinaconazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ertapenem bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Erythromycin Ethyl Succinate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Felbamate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Indomethacin Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Iron Sucrose bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Labetalol Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Lanthanum Carbonate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Lumefantrine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Mebendazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Midazolam bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Milnacipran Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Naproxen bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Naproxen Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Pantoprazole Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Patiromer Sorbitex Calcium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Pregabalin bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Quinapril bulk offered by Solara Active Pharma Sciences

    Find a price of Ranitidine bulk offered by Solara Active Pharma Sciences

    Find a price of Sodium Zirconium Cyclosilicate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Succinylcholine Chloride bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Sugammadex Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ursodeoxycholic Acid bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Venlafaxine Hydrochloride bulk with CEP offered by Solara Active Pharma Sciences

    Find a price of Zidovudine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Mefenamic acid, Solara bulk with CEP offered by Solara Active Pharma Sciences

    Find a price of Chlorphenesin bulk offered by Solara Active Pharma Sciences

    Find a price of Cinacalcet Hydrochloride bulk offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Lysinate bulk offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Sodium bulk offered by Solara Active Pharma Sciences

    Find a price of Lacidipine bulk offered by Solara Active Pharma Sciences

    Find a price of Mesalazine bulk offered by Solara Active Pharma Sciences

    Find a price of Nabumetone bulk offered by Solara Active Pharma Sciences

    Find a price of Naproxen bulk offered by Solara Active Pharma Sciences

    Find a price of Naproxen Sodium bulk offered by Solara Active Pharma Sciences

    Find a price of Ranitidine Hydrochloride bulk offered by Solara Active Pharma Sciences

    Find a price of Sulfasalazine bulk offered by Solara Active Pharma Sciences

    Find a price of Carbidopa bulk offered by Solara Active Pharma Sciences

    Find a price of Choline Chloride bulk offered by Solara Active Pharma Sciences

    Find a price of Edoxaban Tosylate bulk offered by Solara Active Pharma Sciences

    Find a price of Etilevodopa bulk offered by Solara Active Pharma Sciences

    Find a price of Favipiravir bulk offered by Solara Active Pharma Sciences

    Find a price of Gabapentin bulk offered by Solara Active Pharma Sciences

    Find a price of Iron Sucrose bulk offered by Solara Active Pharma Sciences

    Find a price of Levetiracetam bulk offered by Solara Active Pharma Sciences

    Find a price of Loxoprofen Sodium bulk offered by Solara Active Pharma Sciences

    Find a price of Migalastat bulk offered by Solara Active Pharma Sciences

    Find a price of Nizatidine bulk offered by Solara Active Pharma Sciences

    Find a price of Olanzapine bulk offered by Solara Active Pharma Sciences

    Find a price of Oseltamivir Phosphate bulk offered by Solara Active Pharma Sciences

    Find a price of Patiromer bulk offered by Solara Active Pharma Sciences

    Find a price of Pitavastatin bulk offered by Solara Active Pharma Sciences

    Find a price of Sertraline Hydrochloride bulk offered by Solara Active Pharma Sciences

    Find a price of Sevelamer Carbonate bulk offered by Solara Active Pharma Sciences

    Find a price of Tranexamic Acid bulk offered by Solara Active Pharma Sciences

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search